Japanese encephalitis vaccine - Bharat Biotech

Drug Profile

Japanese encephalitis vaccine - Bharat Biotech

Alternative Names: Jenvac

Latest Information Update: 02 Sep 2016

Price : $50

At a glance

  • Originator Bharat Biotech
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Japanese encephalitis

Most Recent Events

  • 04 Oct 2013 Launched for Japanese encephalitis (prevention) in India (IM)
  • 28 Aug 2013 Phase-III clinical trials in Japanese encephalitis (prevention) in India before 2013 (IM)
  • 06 Jul 2012 Registered for Japanese encephalitis (prevention) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top